University of California and Elsevier Sign Ground-Breaking Transformative Agreement
Four-year agreement supports University of California's transition to Open Access Test and learn approach will implement UC's pioneering shared funding...
Month: March 2021
XORTX to Present at “Zoom With LD MICRO”
CALGARY, AB / ACCESSWIRE / March 16, 2021 / XORTX Therapeutics Inc. ("XORTX" or the "Company") (CSE:XRX) (OTCQB:XRTXF), a biopharmaceutical...
Following Winter Storm Crisis, American Kidney Fund Reports $325,000 in Disaster Relief to Texas Patients
AKF thanks corporate donors who helped AKF mobilize Disaster Relief Program ROCKVILLE, MD / ACCESSWIRE / March 16, 2021 / When the...
NephroSant Announces $16 Million Series A, Led by DaVita Venture Group
SAN FRANCISCO, CA / ACCESSWIRE / March 16, 2021 / NephroSant, a kidney health spin out of UC San Francisco,...
Halberd Corporation Starts VITA-SHIELD-MAX(TM) Immunity Boosting Nutraceutical Production
JACKSON CENTER, PA / ACCESSWIRE / March 16, 2021 / Halberd Corporation (OTC PINK:HALB) has contracted with a major nutraceutical...
Stella Diagnostics and the University of Kansas Medical Center Enter Into Collaborative Research Agreement
KANSAS CITY, KS / ACCESSWIRE / March 16, 2021 / Stella Diagnostics, Inc. (OTC PINK:JMDP) ("Stella" or "The Company") has...
Modular Medical Relocates to Larger Corporate Headquarters
The 7,300 square foot facility features a clean-room manufacturing environment and environmentally controlled test labs SAN DIEGO, CA / ACCESSWIRE...
NeoGenomics and Elevation Oncology Announce Collaboration to Expand Genomic Testing for NRG1 Fusions Across Solid Tumors in Support of the Phase 2 CRESTONE Study
Clinical Trial Matching Collaboration Will Enhance Identification of Patients with Any Solid Tumor Harboring an NRG1 Gene Fusion Identified Using...
Havn Life Introduces Industry Leader Jenna Pozar as Chief Operating Officer
Pozar will lead sales, marketing, e-commerce and logistics for Havn Retail VANCOUVER, BC / ACCESSWIRE / March 16, 2021 /...
Planet 13’s Award-Winning Brands Now Available in 53 Dispensaries Across Nevada
LAS VEGAS, NV / ACCESSWIRE / March 16, 2021 / Planet 13 Holdings Inc. (CSE:PLTH)(OTCQB:PLNHF) ("Planet 13" or the "Company"), a...
Rapid Micro Biosystems Raises $81M to Continue Global Expansion of Automated Pharmaceutical QC Platform to Improve Data Integrity and Safety in Biologics, Vaccines, and Cell & Gene Therapy Manufacturing
LOWELL, Mass., March 16, 2021 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc., the leading provider of data integrity and automation...
UMC Health System Implements Retia Medical’s Argos Cardiac Output Monitors Across Multiple ICUs
VALHALLA, N.Y., March 16, 2021 (GLOBE NEWSWIRE) -- Retia Medical announced today the successful installation of its Argos Cardiac Output...
Optimi Health Receives Health Canada NPN Product Licenses in Preparation for Q2 Sales Launch
--Company Introduces Celebrity Wellness Expert Harley Pasternak as Advisor VANCOUVER, British Columbia, March 16, 2021 (GLOBE NEWSWIRE) -- Optimi Health...
Pure Extracts Orders First Shipment of Functional Mushrooms for e-Commerce Store
VANCOUVER, British Columbia, March 16, 2021 (GLOBE NEWSWIRE) -- Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) (“Pure...
MannKind Announces Closing of Initial Purchasers’ Option to Purchase Additional Convertible Senior Notes
WESTLAKE VILLAGE, Calif., March 16, 2021 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) today announced that on March 15, 2021 it issued...
CohBar Nominates CB5138 Analog as Lead Clinical Candidate for Idiopathic Pulmonary Fibrosis and other Fibrotic Diseases
MENLO PARK, Calif., March 16, 2021 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria...
Chiesi USA Announces Sponsorship of ASHP Foundation’s Pharmacy Leadership Scholars Program
Program advances research in diversity, equity and inclusion in healthcareCARY, N.C., March 16, 2021 (GLOBE NEWSWIRE) -- Chiesi USA (key-ay-zee),...
Cannalogue Now Accepting Requests for Clinical Trials and Research with Medical CBD
Medical cannabis provider aims to accelerate research efforts throughout North AmericaTORONTO, March 16, 2021 (GLOBE NEWSWIRE) -- Canada’s leading provider...
Advaxis Reports First Quarter Ended January 31, 2021 Financial Results and Provides a Business Update
Continued enrollment in expanded ADXS-503 HOT program in NSCLC to explore potential to enhance and/or restore sensitivity to checkpoint inhibitors...
Arch Biopartners Receives Health Canada Authorization to Amend Phase II Trial Protocol for LSALT Peptide
TORONTO, March 16, 2021 (GLOBE NEWSWIRE) -- Arch Biopartners Inc. (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF),...